Post-approval studies (Phase 4)Study completedNCT01191541What this trial is testingCytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)Who this might be right forLeukemia Xiaofan Zhu 65
Not applicableLooking for participantsNCT07522905What this trial is testingVirtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in RemissionWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Comenius University 24
Not applicableLooking for participantsNCT07805096What this trial is testingEfficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual HealthWho this might be right forLeukemia (Both ALL and AML)Brain Tumors National Defense Medical University, Taiwan 120
Not applicableLooking for participantsNCT06131801What this trial is testingPharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a SolutionWho this might be right forHematologic MalignancyLeukemiaLymphoma+16 more Children's Hospital Medical Center, Cincinnati 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03628612What this trial is testingLong-term Follow-up of Patients Treated With Genetically Modified Autologous T CellsWho this might be right forPatients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell TherapyMultiple MyelomaDLBCL+2 more Autolus Limited 500
Not applicableLooking for participantsNCT06274788What this trial is testingSafety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentWho this might be right forParenteral Nutrition Associated Liver Disease (PNALD)Essential Fatty Acid DeficiencyMalnutrition+1 more Fresenius Kabi 40
Testing effectiveness (Phase 2)WithdrawnNCT05320380What this trial is testingThe Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatWho this might be right forRecurrent Acute Myeloid LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute Leukemia+5 more Children's Oncology Group
Not applicableUnknownNCT01619124What this trial is testingOsteonecroses in Pediatric Patients With ALLWho this might be right forOsteonecrosisAcute Lymphoblastic LeukaemiaLymphoblastic Lymphoma Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu 400
Not applicableWithdrawnNCT06013904What this trial is testingDifficult PIV Placement in the Pediatric EDWho this might be right forPediatric ALL University of Texas at Austin
Testing effectiveness (Phase 2)Looking for participantsNCT03676504What this trial is testingTreatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CARWho this might be right forAcute Lymphoblastic Leukemia, AdultAcute Lymphoblastic Leukemia, PediatricChronic Lymphocytic Leukemia+3 more University Hospital Heidelberg 68
Testing effectiveness (Phase 2)Looking for participantsNCT07256210What this trial is testingFeasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic T-cell LeukemiaMixed Phenotype Acute Leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Not applicableNo Longer AvailableNCT05215405What this trial is testingExpanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LLWho this might be right forRelapsed Childhood ALLRelapsed Childhood Lymphoblastic Lymphoma Kathleen Ludwig
Not applicableStudy completedNCT05964322What this trial is testingCardiac Rehabilitation of Children and Adolescent With Long QT SyndromeWho this might be right forLong QT SyndromeCongenital Long Qt SyndromeInherited Cardiac Conduction Disorder+1 more University Hospital, Montpellier 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05460533What this trial is testingA Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)Who this might be right forB-cell Acute Lymphoblastic Leukemia Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00930098What this trial is testingA Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic LeukaemiaWho this might be right forAcute Lymphoblastic Leukemia Genzyme, a Sanofi Company 74
Testing effectiveness (Phase 2)Ended earlyNCT03860844What this trial is testingIsatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Sanofi 67
Early research (Phase 1)Study completedNCT00079404What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaWho this might be right forAcute Undifferentiated LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid Leukemia+2 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT03384654What this trial is testingEvaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Janssen Research & Development, LLC 47
Not applicableStudy completedNCT01629745What this trial is testingGenetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 TrialWho this might be right forLeukemia Children's Oncology Group 99
Early research (Phase 1)Study completedNCT00022451What this trial is testingTipifarnib in Treating Young Patients With Refractory LeukemiaWho this might be right forLeukemia National Institutes of Health Clinical Center (CC)